Association of concomitant H1 antihistamine and immune checkpoint inhibitor therapy on survival outcome and safety in patients with advanced primary lung cancer: a cohort study
联合使用H1抗组胺药和免疫检查点抑制剂治疗对晚期原发性肺癌患者生存结局和安全性的影响:一项队列研究
期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-24-795
Zhang, Wei-Hong; Li, Bing-Xue; Ma, Chen-Xi; Wang, Jian; Yang, Fan; Xiong, Yan-Juan; Li, Shu-Zhan; Zhang, Jia-Li; Du, Wei-Jiao; Hui, Zhen-Zhen; Shen, Meng; Zhou, Li; Li, Run-Mei; Tian, Xiao; Han, Ying; Ren, Bao-Zhu; Ichiki, Yoshinobu; Lee, Sang Chul; Zhang, Xin-Wei; Cao, Shui; Ren, Xiu-Bao; Liu, Liang